Literature DB >> 20057963

Significance of cellular senescence in aging and cancer.

Angela Grimes1, Sathees B C Chandra.   

Abstract

Cellular senescence is a mechanism that induces an irreversible growth arrest in all somatic cells. Senescent cells are metabolically active but lack the capacity to replicate. Evolutionary theories suggest that cellular senescence is related to the organismal decline occurring in aging organisms. Also, such theories describe senescence as an antagonistically pleiotropic process that can have beneficial or detrimental effect on the organism. Cellular senescence is believed to be involved in the cellular changes observed as aging progresses. Accumulation of senescent cells appears to occur widely as the organism ages. Furthermore, senescence is a key element of the tumor suppressor pathways. Therefore, it is part of the natural barrier against the uncontrolled proliferation observed in cellular development of malignancies in multicellular organisms. Activation of the senescence process guarantees a limited number of cellular replications. The genetic network led by p53 is responsible for activation of senescence in response to DNA damage and genomic instability that could lead to cancer. A better comprehension of the genetic networks that control the cell cycle and induce senescence is important to analyze the association of senescence to longevity and diseases related to aging. For these reasons, experimental research both in vitro and in vivo aims to develop anticancer therapies based on senescence activation. The last decade of research on role and function of senescence in aging and cancer are discussed in this paper.

Entities:  

Keywords:  Aging; Genetic pathways; Neoplasms; Pleiotropy; Telomere

Year:  2009        PMID: 20057963      PMCID: PMC2802848          DOI: 10.4143/crt.2009.41.4.187

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  97 in total

1.  Senescence induced by altered telomere state, not telomere loss.

Authors:  Jan Karlseder; Agata Smogorzewska; Titia de Lange
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

2.  A test of evolutionary theories of aging.

Authors:  Kimberly A Hughes; Julie A Alipaz; Jenny M Drnevich; Rose M Reynolds
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-17       Impact factor: 11.205

3.  A DNA damage checkpoint response in telomere-initiated senescence.

Authors:  Fabrizio d'Adda di Fagagna; Philip M Reaper; Lorena Clay-Farrace; Heike Fiegler; Philippa Carr; Thomas Von Zglinicki; Gabriele Saretzki; Nigel P Carter; Stephen P Jackson
Journal:  Nature       Date:  2003-11-05       Impact factor: 49.962

4.  Telomere length and the expression of natural telomeric genes in human fibroblasts.

Authors:  Yi Ning; Jing-Fan Xu; Yu Li; Liz Chavez; Harold C Riethman; Peter M Lansdorp; Nan-Ping Weng
Journal:  Hum Mol Genet       Date:  2003-06-01       Impact factor: 6.150

Review 5.  Many ways to telomere dysfunction: in vivo studies using mouse models.

Authors:  Fermín A Goytisolo; María A Blasco
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

6.  Testing an 'aging gene' in long-lived drosophila strains: increased longevity depends on sex and genetic background.

Authors:  Christine C Spencer; Christine E Howell; Amber R Wright; Daniel E L Promislow
Journal:  Aging Cell       Date:  2003-04       Impact factor: 9.304

7.  Adaptive variation in senescence: reproductive lifespan in a wild salmon population.

Authors:  Andrew P Hendry; Yolanda E Morbey; Ole K Berg; John K Wenburg
Journal:  Proc Biol Sci       Date:  2004-02-07       Impact factor: 5.349

8.  A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.

Authors:  James G Rheinwald; William C Hahn; Matthew R Ramsey; Jenny Y Wu; Zongyou Guo; Hensin Tsao; Michele De Luca; Caterina Catricalà; Kathleen M O'Toole
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

9.  Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence.

Authors:  Frédérick A Mallette; Stéphane Goumard; Marie-France Gaumont-Leclerc; Olga Moiseeva; Gerardo Ferbeyre
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

10.  Epigenetic silencing of multiple interferon pathway genes after cellular immortalization.

Authors:  Olga I Kulaeva; Sorin Draghici; Lin Tang; Janice M Kraniak; Susan J Land; Michael A Tainsky
Journal:  Oncogene       Date:  2003-06-26       Impact factor: 9.867

View more
  16 in total

1.  Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway.

Authors:  Jeng-Jer Shieh; Chun-Ying Wu; Sin-Ting Wang; Shi-Wei Huang; Kuang-Ting Liu; Teng-Yu Lee
Journal:  Cell Death Discov       Date:  2020-03-30

2.  Cristacarpin promotes ER stress-mediated ROS generation leading to premature senescence by activation of p21(waf-1).

Authors:  Souneek Chakraborty; Reyaz Ur Rasool; Sunil Kumar; Debasis Nayak; Bilal Rah; Archana Katoch; Hina Amin; Asif Ali; Anindya Goswami
Journal:  Age (Dordr)       Date:  2016-05-31

3.  Protein carbamylation is a hallmark of aging.

Authors:  Laëtitia Gorisse; Christine Pietrement; Vincent Vuiblet; Christian E H Schmelzer; Martin Köhler; Laurent Duca; Laurent Debelle; Paul Fornès; Stéphane Jaisson; Philippe Gillery
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

4.  The ATM cofactor ATMIN protects against oxidative stress and accumulation of DNA damage in the aging brain.

Authors:  Nnennaya Kanu; Kay Penicud; Mariya Hristova; Barnaby Wong; Elaine Irvine; Florian Plattner; Gennadij Raivich; Axel Behrens
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

5.  New biomarkers probing depth of cell senescence assessed by laser scanning cytometry.

Authors:  Hong Zhao; H Dorota Halicka; Frank Traganos; Ellen Jorgensen; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2010-11       Impact factor: 4.355

Review 6.  Management of pancreatic cancer in the elderly.

Authors:  Oliver Higuera; Ismael Ghanem; Rula Nasimi; Isabel Prieto; Laura Koren; Jaime Feliu
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

7.  Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells.

Authors:  Alexander A Goldberg; Adam Beach; Gerald F Davies; Troy A A Harkness; Andréa Leblanc; Vladimir I Titorenko
Journal:  Oncotarget       Date:  2011-10

8.  Integrative analysis of methylation and transcriptional profiles to predict aging and construct aging specific cross-tissue networks.

Authors:  Yin Wang; Tao Huang; Lu Xie; Lei Liu
Journal:  BMC Syst Biol       Date:  2016-12-23

9.  Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesis.

Authors:  Gokhan Yildiz; Ayca Arslan-Ergul; Sevgi Bagislar; Ozlen Konu; Haluk Yuzugullu; Ozge Gursoy-Yuzugullu; Nuri Ozturk; Cigdem Ozen; Hilal Ozdag; Esra Erdal; Sedat Karademir; Ozgul Sagol; Dilsa Mizrak; Hakan Bozkaya; Hakki Gokhan Ilk; Ozlem Ilk; Biter Bilen; Rengul Cetin-Atalay; Nejat Akar; Mehmet Ozturk
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

10.  Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss.

Authors:  Pablo César Ortiz-Lazareno; Alejandro Bravo-Cuellar; José Manuel Lerma-Díaz; Luis Felipe Jave-Suárez; Adriana Aguilar-Lemarroy; Jorge Ramiro Domínguez-Rodríguez; Oscar González-Ramella; Ruth De Célis; Paulina Gómez-Lomelí; Georgina Hernández-Flores
Journal:  Cancer Cell Int       Date:  2014-02-04       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.